Related Articles
The heat shock protein 90 inhibitor SNX-2112 inhibits B16 melanoma cell growth in vitro and in vivo
Hsp90 inhibition by WK88-1 potently suppresses the growth of gefitinib-resistant H1975 cells harboring the T790M mutation in EGFR
HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review)
BIIB021, an Hsp90 inhibitor: A promising therapeutic strategy for blood malignancies (Review)
Ganetespib induces G2/M cell cycle arrest and apoptosis in gastric cancer cells through targeting of receptor tyrosine kinase signaling